Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

NCT06685042 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Systemic
System; Sclerosis
ANCA Associated Vasculitis
Dermatomyositis
Polymyositis

Interventions

BIOLOGICAL: CAR T cell

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS